
Director of Late-Stage Program Management (Phase 3 COO)
Scorpion Therapeutics, Somerville, ME, United States
A biotechnology company in Somerville is seeking a motivated Director/Sr. Director for its advanced program GB-0895, overseeing program management during multiple Phase 3 trials. Candidates should have a minimum of 12 years in the biopharma sector, with 8 years in program management focusing on late-stage clinical trials and BLA submissions. This role demands excellent leadership and interpersonal skills to drive program success while maintaining positive stakeholder relationships. An onsite presence is expected with relocation options available.
#J-18808-Ljbffr